Elixir Medical Announces Outstanding Long-Term Clinical Results at EuroPCR for World’s Broadest Portfolio of Three CE ...

Elixir Medical Corporation, a developer of products that combine state-of-the-art medical devices with advanced pharmaceuticals, announced today excellent long-term results of its CE Mark-approved DESyne Novolimus Eluting Coronary Stent System and CE Mark-approved DESyne BD Novolimus Eluting Coronary Stent System with biodegradable polymer, both compared to the control Endeavor Zotarolimus ...



from Google News, Yahoo! News, Wikinews, NY Times National News by search term http://ift.tt/1n9sd3c

via IFTTT